HEPA
Hepion Pharmaceuticals, Inc.
NASDAQ · Healthcare · Biotechnology · US
$0.09
+33.33%Margins
Gross margin
—
EBITDA margin
—
EBIT margin
—
Net margin
—
FCF margin
—
-249.4%
Return on equity
-165.4%
Return on assets
-246.2%
Return on invested capital
0.00x
Asset turnover
-$1.6M
Cash from operations
$0.14
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026